Community pharmacies and BioPharma: Advancing whole-patient care together

Community pharmacies and BioPharma: Advancing whole-patient care together

2025-10-27 — BioPharma Dive

Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together The healthcare landscape has never been more complex, with the population aging and more people developing complex…


Older Patients and Women Bear the Brunt of CTD-ILD Burden

Older Patients and Women Bear the Brunt of CTD-ILD Burden

2025-10-27 — Rheumatology Advisor

CTD-ILD Burden on Older Patients and Women The incidence and prevalence of CTD-ILD significantly impact adults in the US, particularly old…

Rates of Physician Attrition From Clinical Practice Have Risen Since 2013

Rates of Physician Attrition From Clinical Practice Have Risen Since 2013

2025-10-27 — Pulmonology Advisor

Physician Attrition from Clinical Practice on the Rise A recent study has found that the rate of physician attrition from clinical practic…

TSX Today: What to Watch for in Stocks on Monday, October 27

TSX Today: What to Watch for in Stocks on Monday, October 27

2025-10-27 — The Motley Fool Canada

TSX Today: What to Watch for in Stocks on Monday, October 27 With oil and copper trending higher but gold easing, the TSX could trade side…

Kaladze on Georgia’s absence from Euronest session: Our platform is our country and its people

Kaladze on Georgia’s absence from Euronest session: Our platform is our country and its people

2025-10-27 — Georgia Today

Georgia's Absence from Euronest Session Tbilisi Mayor Kakha Kaladze commented on the Georgian delegation's non-participation in the Eurone…

VIDEO: Rolls-Royce in high speed sector methanol engine world first

VIDEO: Rolls-Royce in high speed sector methanol engine world first

2025-10-27 — Marine Log

Rolls-Royce Achieves World First with Methanol Engine Rolls-Royce Power Systems has successfully tested a high-speed marine engine powered…

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

2025-10-27 — FinanzNachrichten.de

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…

Expanded Rolex 24 Grid “Not Possible” Due to Pit Lane Space – Sportscar365

Expanded Rolex 24 Grid “Not Possible” Due to Pit Lane Space – Sportscar365

2025-10-27 — Sportscar365

Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that it's currently "not possible" to accommo…

Here’s why Utah’s Olympic organizers are in NYC this week

Here’s why Utah’s Olympic organizers are in NYC this week

2025-10-27 — Deseret News

Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …

Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper

Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper

2025-10-27 — The Non-League Football Paper

Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

2025-10-27 — FinanzNachrichten.de

Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…

© 2025 zofran.cfd News Aggregator
About Us · Privacy Policy · Terms of Service · DMCA Notice